The US CMS has been commended by pharmaceutical company Chiron Corporation for implementing a reimbursement change on 1 October that will increase access to high-dose interleukin-2 (IL-2)

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.433, 2003-01, pp. : 12-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Funding in the amount of $US1 million has been pledged by US-based pharmaceutical giant Wyeth

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 365, 2002-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Ezetimibe has been launched by the Indian pharmaceutical company, Lupin, in India

By  

Inpharma, Vol. 1, Iss. 1422, 2004-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

The US government's plans to end the pay-for-delay agreements between pharmaceutical and generic companies has been criticised

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 623, 2011-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

A bill has been introduced into the US Senate that aims to increase the safety of prescription medications

By  

Reactions Weekly, Vol. 1, Iss. 1120, 2006-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

A bill has been introduced into the US Senate that aims to increase the safety of prescription medications

By  

Inpharma, Vol. 1, Iss. 1557, 2006-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite